Compare Crocs, Inc. (CROX) vs GSK plc (GSK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Crocs, Inc. vs GSK plc — how do they compare? Crocs, Inc. trades at $131.61 (market cap $6.31B), while GSK plc trades at $50.5 (market cap $102.60B). The key difference: GSK plc is far larger — about 16.3× Crocs, Inc.'s market cap, and GSK plc pays a 3.57% dividend while Crocs, Inc. pays none. Which is the better fit depends on your goals.
| CROX | GSK | |
|---|---|---|
Market Cap | $6.31B | $102.60B |
Sector | Consumer Staples | Health |
52-Week High | $141.19 | $61.18 |
52-Week Low | $73.39 | $38.22 |
Enterprise Value | $7.83B | $123.04B |
Dividend Yield | — | 3.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Crocs, Inc.
Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children. The reportable geographic segments of the company include Americas, Asia pacific, and EMEA.
Read more on CROX →About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →
